35,793 Shares in HealthEquity, Inc. $HQY Bought by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. bought a new stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 35,793 shares of the company’s stock, valued at approximately $3,166,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Voya Investment Management LLC grew its holdings in HealthEquity by 14.9% during the 3rd quarter. Voya Investment Management LLC now owns 108,771 shares of the company’s stock worth $9,622,000 after acquiring an additional 14,140 shares during the last quarter. Public Sector Pension Investment Board increased its holdings in HealthEquity by 84.4% in the third quarter. Public Sector Pension Investment Board now owns 259,970 shares of the company’s stock worth $23,582,000 after purchasing an additional 119,018 shares in the last quarter. Cibc World Market Inc. bought a new stake in shares of HealthEquity in the 3rd quarter valued at $362,000. Teachers Retirement System of The State of Kentucky raised its holdings in shares of HealthEquity by 3.7% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 56,534 shares of the company’s stock valued at $5,001,000 after purchasing an additional 2,003 shares during the period. Finally, Paralel Advisors LLC raised its stake in HealthEquity by 1.1% during the 3rd quarter. Paralel Advisors LLC now owns 27,975 shares of the company’s stock worth $2,475,000 after buying an additional 314 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on HQY. BMO Capital Markets lifted their price objective on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. Weiss Ratings cut HealthEquity from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday. BTIG Research reaffirmed a “buy” rating and issued a $115.00 price target on shares of HealthEquity in a report on Friday, August 28th. Telsey Advisory Group set a $111.00 price objective on HealthEquity in a report on Friday, August 28th. Finally, Deutsche Bank boosted their price objective on HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a report on Monday, August 31st. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $113.53.

Get Our Latest Report on HQY

HealthEquity Stock Down 4.4%

Shares of NASDAQ:HQY opened at $97.31 on Thursday. The stock’s 50-day moving average price is $96.52 and its 200-day moving average price is $90.23. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $110.26. The stock has a market capitalization of $8.05 billion, a P/E ratio of 35.13, a price-to-earnings-growth ratio of 1.61 and a beta of 0.22. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY – Get Free Report) last released its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The company had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. The company’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities analysts anticipate that HealthEquity, Inc. will post 3.94 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Adrian Dillon sold 7,632 shares of the stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the sale, the director owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.60% of the company’s stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

See Also

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.